Featured Research

from universities, journals, and other organizations

Few physicians refer patients to cancer clinical trials

Date:
February 15, 2011
Source:
Journal of the National Cancer Institute
Summary:
A small proportion of adult cancer patients participate in clinical trials in part due to a low level of physician referrals, according to an new study.

A small proportion of adult cancer patients participate in clinical trials in part due to a low level of physician referrals, according to an online study published Feb. 11 in The Journal of the National Cancer Institute.

Related Articles


Although more than 8000 clinical trials are accepting participants, according to the National Cancer Institute (NCI), only an estimated 2%-4% of newly diagnosed cancer patients participate in them. Prior studies suggest that most eligible patients do not enroll in trials because their physicians do not refer them.

To understand what types of physicians are referring their patients to clinical cancer trials, Carrie N. Klabunde, Ph.D., of NCI, and colleagues, conducted a survey-based study of specialty physicians caring for colorectal and lung cancer patients. The researchers analyzed data from the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) for 1533 oncologists, radiation oncologists, and surgeons caring for colorectal and lung cancer patients. The physicians had completed a survey during 2005-2006.

The researchers found that 869 of the physicians, or 56.7%, responded that they had referred or enrolled at least one patient in clinical trials in the previous 12 months: 87.8% of medical oncologists, 66.1% of radiation oncologists, and 35% of surgeons. Two-thirds of the physicians affiliated with a Community Clinical Oncology Program or an NCI-designated cancer center reported participating in trials.

Furthermore, the researchers write, "Those more likely to participate in a clinical trial were medical or radiation oncologists (vs surgeons), were in larger practices, had academic appointments, saw a higher volume of lung or colorectal cancer patients, and attended weekly tumor board meetings."

The researchers also found that among the physicians who reported referring or enrolling at least one patient in cancer clinical trials in this period, the mean number of patients referred or enrolled was 17.2 for medical oncologists, 9.5 for radiation oncologists, and 12.2 for surgeons. The researchers note that primary care physicians have limited involvement in discussing clinical trial participation with patients; and that financial incentives were associated with physicians' clinical trials accrual volume, a finding consistent with previous studies showing financial incentives influence physician behavior.

The researchers point out certain limitations of their study: the physicians surveyed do not comprise a nationally representative sample; the study is based on physicians' self-reports of their participation in clinical trials; and the measure of trials participation combined patient referral and enrollment.

The researchers conclude that continued monitoring of physician participation in cancer clinical trials is essential. They write, "More research is needed to better understand clinician attitudes toward clinical research and to examine specific features of practice infrastructure -- including availability of support staff, electronic health records, reimbursement, and clinical trial databases -- that facilitate or hinder physician participation in clinical trials."

In an accompanying editorial, Lori M. Minasian, M.D., and Ann M. O'Mara, M.D., of the Community Oncology and Prevention Trials Research Group at the National Cancer Institute (NCI), write that "the American public continues to value medical research," and cite a Mayo clinic study in which 76% of patients said they expected their treating physician to inform them about clinical trials.

The authors also point out that medical students will be required to learn about clinical and translational research, according to a new standard from the Liaison Committee on Medical Education.

The authors conclude: "If we want research to inform practice, we need a workforce of physicians who value the research and understand how to incorporate research results into their practice. Much of the American public looks to their physicians to do that."


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Carrie N. Klabunde, Nancy L. Keating, Arnold L. Potosky, Anita Ambs, Yulei He, Mark C. Hornbrook and Patricia A. Ganz. A Population-Based Assessment of Specialty Physician Involvement in Cancer Clinical Trials. J Natl Cancer Inst, February 11, 2011 DOI: 10.1093/jnci/djq549

Cite This Page:

Journal of the National Cancer Institute. "Few physicians refer patients to cancer clinical trials." ScienceDaily. ScienceDaily, 15 February 2011. <www.sciencedaily.com/releases/2011/02/110211183851.htm>.
Journal of the National Cancer Institute. (2011, February 15). Few physicians refer patients to cancer clinical trials. ScienceDaily. Retrieved January 31, 2015 from www.sciencedaily.com/releases/2011/02/110211183851.htm
Journal of the National Cancer Institute. "Few physicians refer patients to cancer clinical trials." ScienceDaily. www.sciencedaily.com/releases/2011/02/110211183851.htm (accessed January 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, January 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC: Get Vaccinated for Measles

CDC: Get Vaccinated for Measles

Reuters - US Online Video (Jan. 30, 2015) The CDC is urging people to get vaccinated for measles amid an outbreak that began at Disneyland and has now infected more than 90 people. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Obama To Outline New Plan For Personalized Medicine

Obama To Outline New Plan For Personalized Medicine

Newsy (Jan. 30, 2015) President Obama is expected to speak with drugmakers Friday about his Precision Medicine Initiative first introduced last week. Video provided by Newsy
Powered by NewsLook.com
NFL Concussions Down; Still on Parents' Minds

NFL Concussions Down; Still on Parents' Minds

AP (Jan. 30, 2015) The NFL announced this week that the number of game concussions dropped by a quarter over last season. Still, the dangers of the sport still weigh on players, and parents&apos; minds. (Jan. 30) Video provided by AP
Powered by NewsLook.com
U.S. Wants to Analyze DNA from 1 Million People

U.S. Wants to Analyze DNA from 1 Million People

Reuters - US Online Video (Jan. 30, 2015) The U.S. has proposed analyzing genetic information from more than 1 million American volunteers to learn how genetic variants affect health and disease. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins